Published in Drug Week, December 2nd, 2005
The findings are reported in a recent issue of Current Biology; they were studied in mice bred to develop the disease, called neurofibromatosis 1 (NF1).
The results proved so hopeful, that the U.S Food and Drug Administration (FDA) approved the use of the drugs in 3 clinical trials currently under review to test the effect of statins in children...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.